15 December 2008
Lectus Therapeutics announces development milestone

10 September 2008
Lectus Therapeutics appoints new chairman, strengthens main and advisory boards

5 September 2007
Lectus Therapeutics secures £3million investment from the Wellcome Trust

24 July 2007
Lectus Therapeutics strengthens management team and SAB

15 May 2007
Lectus Therapeutics wins ERBI’s Innovation in Drug Discovery and Development Award.

8 January 2007
Lectus Therapeutics announces preclinical ‘Proof-of-Concept’ data.

26 September 2006
Lectus Therapeutics Announces Relocation to Cambridge.

19 April 2006
Lectus Therapeutics Acquires NeuroServe.

13 February 2006
Lectus Therapeutics closes Series A funding round raising £8.2 million.

2 August 2004
Lectus Therapeutics announces chemistry collaboration with Evotec OAI.

6 May 2004
Lectus Therapeutics announces strategic investment from Takeda Research Investment to advance discovery programmes for next-generation ion channel drugs.

3 November 2003
Lectus Therapeutics Ltd announces financing from the SULIS Seedcorn Fund.